News brief
On 2026-2-9, according to Xiniu Data, Iambic Therapeutics was acquired for USD 1.7 billion. Investors were Takeda Pharmaceutical Co.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.iambic.ai ↗Published Feb 9, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年2月9日，据烯牛数据报道，Iambic Therapeutics被收购，金额17亿美元。投资方为Takeda Pharmaceutical Co。